Drug Discovery

Cost optimization in Drug discovery is a key strategy for pharmaceutical companies. However, improperly designed clinical trials, unsuitable patient population, and lack of competitive differentiation result in drug failures. Analytics can transform growth by mapping clinical trial trends to identifying risks, highlighting the gaps in the efficacy and safety of drugs and narrowing down on test sites, accelerating drug discovery and development. LERA’s solution analysis helps the health care organizations treat patients holistically and provide personalized care to enhance health outcomes and help the organization to understand the patient’s needs.